Scholar Rock Holding SRRK
NASDAQ SRRK
$55.46 -0.48 (-0.86%)
As of: Sep 4, 2026 · 2:35 PM EDT

Scholar Rock Holding (SRRK) Change in Account Payables (2017 - 2026)

Scholar Rock Holding (SRRK) posted quarterly Change in Account Payables of -$1.1 million for Q1 2026, up 80.82% year-over-year from -$600032.3 in Q1 2025, and down 130.66% quarter-over-quarter from $3.5 million in Q4 2025.

Analysis

Scholar Rock Holding (SRRK) Change in Account Payables (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Change in Account Payables history runs 10 years deep, the most recent figure standing at -$1.1 million for Q1 2026.

  • In Q1 2026, Change in Account Payables rose 80.82% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at $4.8 million (up 202.21% YoY), while the FY2025 annual figure was $208000.0, down 96.86% from the prior year.
  • Change in Account Payables for Q1 2026 stood at -$1.1 million, down from $3.5 million in the prior quarter.
  • The five-year high for Change in Account Payables was $6.0 million in Q4 2024, with the low at -$5.7 million in Q1 2025.
  • The 5-year median for Change in Account Payables is -$274000.0 (2023), against an average of $292529.4.
  • Peak annual rise in Change in Account Payables reached 648.68% in 2025, while the deepest fall reached 827.54% in 2025.
  • Scholar Rock Holding's Change in Account Payables stood at $2.0 million in 2022, then slipped by 24.92% to $1.5 million in 2023, then jumped by 302.4% to $6.0 million in 2024, then tumbled by 41.25% to $3.5 million in 2025, then slumped by 130.66% to -$1.1 million in 2026.
  • Business Quant data shows SRRK's Change in Account Payables at -$1.1 million in Q1 2026, $3.5 million in Q4 2025, and $5.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn -
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - 5.03 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn -
8 Royalty Pharma 28.40 Bn 27.56 Bn - -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn -
10 Scholar Rock Holding 7.25 Bn 7.25 Bn - 1.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.75 Mn
Mar 31, 2026 -1.09 Mn
Dec 31, 2025 3.54 Mn
Sep 30, 2025 5.66 Mn
Jun 30, 2025 -3.33 Mn
Mar 31, 2025 -5.66 Mn
Dec 31, 2024 6.02 Mn
Sep 30, 2024 756,000.00
Jun 30, 2024 460,000.00
Mar 31, 2024 -610,000.00
Dec 31, 2023 1.50 Mn
Sep 30, 2023 -1.08 Mn
Jun 30, 2023 -676,000.00
Mar 31, 2023 -274,000.00
Dec 31, 2022 1.99 Mn
Sep 30, 2022 -851,000.00
Jun 30, 2022 186,000.00
Mar 31, 2022 -1.58 Mn
Dec 31, 2021 2.21 Mn
Sep 30, 2021 585,000.00